Touchdown! NFL Refs Return to Field Thursday

Not to knock the referees that filled-in during the lock-out of NFL officials as they did a pedestrian job, but the atrocious call on Monday Night Football between the Seahawks and the Packers was just about enough of the replacements. Today, the National Football League said that a new eight-year deal with the NFL Referees Association has been struck and the NFL zebras will be returning to the field for tonight’s game between Cleveland and Baltimore.

The agreement, which represents the longest with game officials in NFL history, still needs ratification from the referee membership, the NFL Commissioner Roger Goodell has temporarily lifted the lockout until that happens.

The labor dispute revolved around several issues, including salary, pension and retirement benefits for the officials, who are part-time employees of the league. Amongst other things in the tentative agreement, refs’ salaries will increase from an average of $149,000 per year in 2011 to $173,000 in 2013 to $205,000 by 2019.

“We are glad to be getting back on the field for this week’s games,” referees’ union president Scott Green said.

Now, let’s get back to scrutinizing the refs that get paid a whole lot more.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Stock Markets Close Ahead of Frankenstorm(0) With the East Coast bracing for what could be the biggest storm ever to come inland, Wall Street regulators have decided to shutter their doors on Monday and possibly Tuesday. Hurricane Sandy, dubbed “Frankenstorm” because of its massive size and potentially destructive nature, started hitting the eastern seaboard of the United States early Monday morning.

	Willa Acquisition Will Springboard Discovery Ventures into Production(0) Mining investors looking for promising upstarts are often left with the daunting task of sifting through a raft of companies and reports to separate the wheat from the chaff and maximize potential gains. It’s worth the time, though, because there is a wide gap between the number of developmental companies and companies in production. Smaller

	InspireMD Stents Meet Endpoint and Outperform Standards of Care Today(0) The biotechnology sector, as well as the healthcare sector, have been some of the strongest performers throughout 2012 even though biotech Exchange Traded Funds are cooling over the past week which has carved away at some of the yearly gains. For example, the SPDR S&P Biotech Index ETF (XBI) is still holding gains above 30

	Markets Fall on Wednesday, Dow Jones Down Four out of Five Days(0) Stocks traded in a narrow range Wednesday afternoon, as investors found little reason to place any big bets with earnings season in full-bloom. Earnings and outlooks are keeping investors on the sidelines as business overseas is hamstringing growth for major corporations. The Wall Street slide on Wednesday added to triple-digit losses on Tuesday and made

	Excellagen Presentation on Cardium Therapeutics Website(0) An updated presentation for Excellagen has been published on the Cardium Therapeutics (NYSE MKT: CXM) website. The pdf file is available for viewing/dowloading at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations. Recently voted as a top ten podiatry innovations in 2012 by the publication Podiatry Today, Excellagen is an FDA-cleared formulated collagen topical gel (2.6%) designed for use with debridement and

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.